| RS1562914212 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Hereditary pancreatitis |
| RS1562914641 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562914838 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562917450 |
BBS9
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1562917629 |
CCM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562919371 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562919685 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1562921605 |
CCM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1562922141 |
SYNE1
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 3, myogenic type |
| RS1562923164 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562923253 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562925631 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1562927768 |
KMT2E
|
Health Risk |
Pathogenic/Likely pathogenic |
O'Donnell-Luria-Rodan syndrome, See cases |
| RS1562928193 |
KMT2E
|
Health Risk |
Pathogenic |
Intellectual disability, O'Donnell-Luria-Rodan syndrome |
| RS1562928854 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562928927 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562928997 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS1562929196 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1562929573 |
CFTR
|
Health Risk |
Likely pathogenic |
— |
| RS1562929623 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1562929633 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562929636 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1562931107 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome, Cardiofaciocutaneous syndrome 1 |
| RS1562931936 |
KMT2E
|
Health Risk |
Likely pathogenic |
See cases, O'Donnell-Luria-Rodan syndrome |
| RS1562937199 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1562938039 |
AKR1D1
|
Health Risk |
Likely pathogenic |
— |
| RS1562938346 |
KMT2E
|
Health Risk |
Pathogenic |
— |
| RS1562940289 |
TRRAP
|
Health Risk |
Pathogenic |
Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without dysmorphic facies and autism |
| RS1562945106 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without dysmorphic facies and autism |
| RS1562945221 |
ABCB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 1 |
| RS1562949296 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562950567 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1562955153 |
BRAF
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS1562956929 |
BRAF
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS1562957000 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 7, Noonan syndrome 7 |
| RS1562957569 |
TRRAP
|
Health Risk |
Pathogenic |
Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without dysmorphic facies and autism |
| RS1562957576 |
TRRAP
|
Health Risk |
Pathogenic |
Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without dysmorphic facies and autism |
| RS1562957809 |
AUTS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS1562961442 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562961475 |
RELN
|
Health Risk |
Pathogenic |
— |
| RS1562961725 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS1562963055 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562965036 |
ABCB4
|
Health Risk |
Pathogenic |
Cholestasis, intrahepatic |
| RS1562965098 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562965250 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562967226 |
EPHB4
|
Health Risk |
Pathogenic/Likely pathogenic |
EPHB4-related disorder, EPHB4-related disorder |
| RS1562967463 |
EPHB4
|
Health Risk |
Pathogenic |
Lymphatic malformation 7, Lymphatic malformation 7 |
| RS1562969219 |
EPHB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Capillary malformation-arteriovenous malformation 2, EPHB4-related disorder |
| RS1562972354 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562972380 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562973480 |
EPHB4
|
Health Risk |
Pathogenic |
— |
| RS1562973541 |
EPHB4
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS1562973614 |
EPHB4
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS1562975541 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562976061 |
ABCB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 1 |
| RS1562976167 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562976223 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 3, Progressive familial intrahepatic cholestasis |
| RS1562976422 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 3, Cholestasis |
| RS1562976493 |
EPHB4
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS1562977912 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562980610 |
DDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Inborn genetic diseases |
| RS1562980939 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562981766 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562981898 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1562981913 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Long telomere syndrome |
| RS1562983272 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562983531 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562984446 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS1562988165 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562988323 |
PKD1L1
|
Health Risk |
Likely pathogenic |
PKD1L1-related disorder, PKD1L1-related disorder |
| RS1562988883 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Distal myopathy with posterior leg and anterior hand involvement |
| RS1562989885 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1562989913 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 10 |
| RS1562991002 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Hypertrophic cardiomyopathy 26 |
| RS1562991776 |
FLNC
|
Health Risk |
Likely pathogenic |
Myofibrillar myopathy 5, Distal myopathy with posterior leg and anterior hand involvement |
| RS1562992108 |
LAMB1
|
Health Risk |
Pathogenic |
— |
| RS1562993312 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562993384 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562995872 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS1562995883 |
FLNC
|
Health Risk |
Likely pathogenic |
— |
| RS1562996059 |
PKD1L1
|
Health Risk |
Pathogenic |
— |
| RS1562996441 |
FLNC
|
Health Risk |
Pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS1562997249 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562997292 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1562998062 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 26, Cardiovascular phenotype |
| RS1562998089 |
IMPDH1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1562998858 |
FLNC
|
Health Risk |
Pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Myofibrillar myopathy 5 |
| RS1562999443 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Myofibrillar myopathy 5 |
| RS1562999451 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS1563000044 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS1563001456 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Dilated Cardiomyopathy |
| RS1563001474 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 26, Dilated Cardiomyopathy |
| RS1563001548 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Myofibrillar myopathy 5 |
| RS1563003153 |
FLNC
|
Health Risk |
Pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Myofibrillar myopathy 5 |
| RS1563003159 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 26 |
| RS1563003848 |
FLNC
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 26, Hypertrophic cardiomyopathy 26 |
| RS1563003964 |
NCF1
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1563005360 |
FLNC
|
Health Risk |
Pathogenic |
7 conditions, 7 conditions |
| RS1563005534 |
FLNC
|
Health Risk |
Pathogenic |
Restrictive cardiomyopathy, Restrictive cardiomyopathy |
| RS1563005607 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal myopathy with posterior leg and anterior hand involvement, Myofibrillar myopathy 5 |